Yarlagadda S Babu - Net Worth and Insider Trading
Yarlagadda S Babu Net Worth
The estimated net worth of Yarlagadda S Babu is at least $2 Million dollars as of 2024-11-13. Yarlagadda S Babu is the Chief Discovery Officer of BioCryst Pharmaceuticals Inc and owns about 298,541 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $2 Million. Details can be seen in Yarlagadda S Babu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yarlagadda S Babu has not made any transactions after 2022-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yarlagadda S Babu
Yarlagadda S Babu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yarlagadda S Babu owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Yarlagadda S Babu’s form 4 insider trades.
Insider Ownership Summary of Yarlagadda S Babu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-11-14 | VP Drug Discovery |
Yarlagadda S Babu Latest Holdings Summary
Yarlagadda S Babu currently owns a total of 1 stock. Yarlagadda S Babu owns 298,541 shares of BioCryst Pharmaceuticals Inc (BCRX) as of November 14, 2022, with a value of $2 Million.
Latest Holdings of Yarlagadda S Babu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2022-11-14 | 298,541 | 7.82 | 2,334,591 |
Holding Weightings of Yarlagadda S Babu
Yarlagadda S Babu Form 4 Trading Tracker
According to the SEC Form 4 filings, Yarlagadda S Babu has made a total of 4 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 31,515 shares on November 14, 2022, which brought Yarlagadda S Babu around $437,428.
Insider Trading History of Yarlagadda S Babu
- 1
Yarlagadda S Babu Trading Performance
GuruFocus tracks the stock performance after each of Yarlagadda S Babu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yarlagadda S Babu is 72.06%. GuruFocus also compares Yarlagadda S Babu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yarlagadda S Babu within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yarlagadda S Babu's insider trading performs compared to the benchmark.
Performance of Yarlagadda S Babu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 85.88 | | | | | |
| Relative Return to S&P 500(%) | 83.67 | | | | | |
Yarlagadda S Babu Ownership Network
Ownership Network List of Yarlagadda S Babu
Ownership Network Relation of Yarlagadda S Babu
Yarlagadda S Babu Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Yarlagadda S Babu is the VP Drug Discovery of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Yarlagadda S Babu made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Yarlagadda S Babu Mailing Address
Above is the net worth, insider trading, and ownership report for Yarlagadda S Babu. You might contact Yarlagadda S Babu via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
